SOD1 and breast carcinoma: In this regard, it has been determined that the expression of miR-3689a-3p significantly reduced the resistance of breast cancer cells to sorafenib by abrogating SOD1-mediated mitochondrial oxidative stress, which ultimately increased HCC cell death [68].